You are here: Industry Insights > Sensorion

News List

Sensorion and Novasep Sign Agreement contractpharma
November 06, 2020
Covers the development and manufacturing of AAV vectors, a key step for Sensorion’s gene therapy programs.
Sensorion’s PIP is EMA-approved for two indications pharmaceutical-technology
July 03, 2019
Sensorion has received acceptance from the European Medicines Agency (EMA) on its Paediatric Investigation Plan (PIP) for Arazasetron (SENS-401) in two indications.
Sensorion’s vertigo drug hits tolerability endpoint in phase 2 fiercebiotech
December 26, 2018
A phase 2a trial of Sensorion’s vertigo seliforant has met its primary tolerability endpoint. The trial found the histamine type 4 receptor antagonist had .....
Sensorion and Cochlear Announce Collaboration to Study Combination Therapies for Cochlear Implant Pa biospace
December 20, 2017
Sensorion and Cochlear will evaluate SENS-401 in combination with Cochlear’s cochlear implants in preclinical setting in 2018, with potential mid-stage clinical testing to begin as soon as 2019